EFFECTIVENESS AND SAFETY OF SWITCHING FROM INTRAVENOUS TO SUBCUTANEOUS VEDOLIZUMAB FORMULATION IN INFLAMMATORY BOWEL DISEASE PATIENTS IN CLINICAL REMISSION
Laura Parisio 1
Carlo Romano Settanni 1
Daniele Napolitano 1
Simone Varca 1
Elisa Schiavoni 1
Lucrezia Laterza 1
Loris Riccardo Lopetuso 2
Marco Pizzoferrato 2
Stefano Bibbò 2
Norma Alfieri 2
Luisa Guidi 2
Alfredo Papa 3
Antonio Gasbarrini 3
Alessandro Armuzzi 4
Daniela Pugliese 4
Franco Scaldaferri 4
1 Fondazione Policlinico Gemelli, IRCCS, Rome, Italy
2 University of Chieti-Pescara "G. d'Annunzio", Chieti, Italy
3 Università Cattolica del S. Cuore, Roma, Italy
4 Humanitas University, IBD Center, IRCCS Humanitas Research Hospital, Pieve Emanuele, Milan, Italy
Session
IBD (Posters)
Conference
UEG Week 2022
Citation
United European Gastroenterology Journal 2022; 10 (Supplement 8)
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]